Partial breast radiation after lumpectomy in early breast cancer
Part of Cancer clinical trials.
This trial compares a shorter course of radiation focused on part of the breast versus a standard approach after lumpectomy. It aims to see if treating a smaller area can control the cancer while reducing treatment burden.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 50 or older with a new diagnosis of invasive breast cancer
- The cancer has not spread to other organs (no metastatic disease)
- You had a lumpectomy (breast-conserving surgery) with clear margins or no cancer seen again after re-excision
- Your lymph nodes under the arm are not involved, based on surgery and/or tests (especially for smaller, hormone-receptor–positive, HER2-negative tumors planned for hormone therapy)
- Your tumor size is 3 cm or smaller (pathology measurement)
- Your breast cancer matches specific types and patterns (not lobular-only, and certain DCIS/intraductal amounts have limits)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether treating only part of the breast with radiation works as well as treating the whole breast in people with early breast cancer after lumpectomy. It may help reduce radiation exposure to healthy tissue, while still controlling the cancer.
This trial tests whether radiation therapy alone is safe and effective for women 40 and older with early-stage breast cancer who have not had lymph node sampling. It aims to simplify treatment while maintaining good outcomes.
This trial tests a single, targeted radiation treatment given during or after lumpectomy for early-stage breast cancer. It aims to make treatment more convenient while keeping the same safety and effectiveness as longer radiation courses.
This trial tests whether radiation to only part of the breast is safe and effective for women with early-stage breast cancer, without removing lymph nodes. The goal is to reduce side effects while keeping the cancer from coming back.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests a shorter course of radiation to only the part of the breast where cancer has come back. It's for women who had radiation years ago and now have a small new or recurrent tumor that can be removed by surgery.
Hear when a new Breast Neoplasm Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.